Agios Pharmaceuticals (AGIO) Amortizatization of Intangibles (2012 - 2026)

Agios Pharmaceuticals' Amortizatization of Intangibles history runs 15 years deep, the most recent figure standing at $1.1 million for Q1 2026.

• Quarterly Amortizatization of Intangibles fell 15.13% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.0 million (down 47.46% YoY) and the FY2025 annual result came in at $7.2 million, down 50.33% from the prior year.
• Amortizatization of Intangibles was $1.1 million for Q1 2026 at Agios Pharmaceuticals, down from $1.8 million in the prior quarter.
• Across five years, Amortizatization of Intangibles topped out at $5.6 million in Q4 2024 and bottomed at -$1.2 million in Q1 2022.
• A 5-year average of $1.7 million and a median of $1.8 million in 2025 frame the typical range for Amortizatization of Intangibles.
• Peak annual rise in Amortizatization of Intangibles reached 1376.72% in 2023, while the deepest fall reached 263.39% in 2023.
• Agios Pharmaceuticals' Amortizatization of Intangibles stood at $1.9 million in 2022, then sank by 79.52% to $393000.0 in 2023, then jumped by 1329.01% to $5.6 million in 2024, then plunged by 68.79% to $1.8 million in 2025, then plunged by 34.74% to $1.1 million in 2026.
• Business Quant data shows AGIO's Amortizatization of Intangibles at $1.1 million in Q1 2026, $1.8 million in Q4 2025, and $1.7 million in Q3 2025.